As‐Needed Inhaled Corticosteroid‐Formoterol in a Single Inhaler Compared to Inhaled Corticosteroid‐Albuterol in Separate Inhalers as Reliever Therapy in Mild Pediatric Asthma: A Cost‐Utility Analysis
Pediatric Pulmonology · 2025
DOI: 10.1002/ppul.27466 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Pediatric Pulmonology, 2025. Verfasst von Carlos E Rodríguez-Martínez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia. Hauptthemen laut MEDLINE: Asthma, Formoterol Fumarate, Albuterol, Adrenal Cortex Hormones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Objectives
Since 2019 as‐needed low‐dose ICS‐formoterol in a single inhaler has been recommended for treatment of mild asthma in children aged more than 12 years. Alternatively, the use of ICS‐albuterol has been proposed in countries where ICS‐formoterol is not available or affordable. The aim of the present study was to evaluate the cost‐utility of as‐needed ICS‐albuterol in separate inhalers compared to ICS‐formoterol in a single inhaler as reliever therapy in pediatric patients with mild asthma living in Colombia.
Methods
A Markov‐type model was developed to estimate the costs and health outcomes of a simulated cohort of pediatric patients with mild asthma treated for 12 months. The effectiveness data and transition probabilities were obtained from relevant randomized clinical trials (RCTs). Cost data were obtained from official databases provided by the Colombian Ministry of Health. The main outcome was the variable “quality‐adjusted life‐years” (QALYs).
Results
The base‐case analysis showed that compared with the use of as‐needed ICS‐albuterol in separate inhalers, the use of ICS‐formoterol in a single in pediatric patients with mild asthma was associated with lower costs (US$475.51 vs. 735.33 average cost per patient) and the greatest gain in QALYs (0.9367 vs. 0.9352 QALYs on average per patient), thus leading to dominance.
Conclusions
Compared with the use of as‐needed ICS‐albuterol in separate inhalers, the use of ICS‐formoterol in a single inhaler as reliever therapy is cost‐effective in patients aged 12 years or more with mild asthma, because it showed a greater gain in QALYs at lower total treatment costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia.
- Department of Pediatric Pulmonology, School of Medicine, Universidad El Bosque, Bogota, Colombia.
- Department of Internal Medicine, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia.
- Department of Pharmacology and Toxicology, School of Medicine, Research Group in Pharmacology and Toxicology (INFARTO), Universidad de Antioquia, Medellín, Colombia.
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Rodríguez-Martínez, C. E., Sossa-Briceño, M. P., & Buendia, J. A. (2025). As‐Needed Inhaled Corticosteroid‐Formoterol in a Single Inhaler Compared to Inhaled Corticosteroid‐Albuterol in Separate Inhalers as Reliever Therapy in Mild Pediatric Asthma: A Cost‐Utility Analysis. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27466
Vancouver
Rodríguez-Martínez CE, Sossa-Briceño MP, Buendia JA. As‐Needed Inhaled Corticosteroid‐Formoterol in a Single Inhaler Compared to Inhaled Corticosteroid‐Albuterol in Separate Inhalers as Reliever Therapy in Mild Pediatric Asthma: A Cost‐Utility Analysis. Pediatric Pulmonology. 2025. doi:10.1002/ppul.27466
BibTeX
@article{RodrguezMartnez2025,
author = {Rodríguez-Martínez, Carlos E and Sossa-Briceño, Monica P and Buendia, Jefferson Antonio},
title = {As‐Needed Inhaled Corticosteroid‐Formoterol in a Single Inhaler Compared to Inhaled Corticosteroid‐Albuterol in Separate Inhalers as Reliever Therapy in Mild Pediatric Asthma: A Cost‐Utility Analysis},
journal = {Pediatric Pulmonology},
year = {2025},
doi = {10.1002/ppul.27466}
}
EUVIMED